Nephrotoxicity Explained
Nephrotoxicity is toxicity in the kidneys. It is a poisonous effect of some substances, both toxic chemicals and medications, on kidney function.[1] There are various forms,[2] and some drugs may affect kidney function in more than one way. Nephrotoxins are substances displaying nephrotoxicity.
Nephrotoxicity should not be confused with some medications predominantly excreted by the kidneys needing their dose adjusted for the decreased kidney function (e.g., heparin, lithium).
Types of toxicity
Cardiovascular
Direct tubular effect
- Proximal convoluted tubule: Aminoglycoside antibiotics (e.g., gentamicin), amphotericin B, cisplatin, radiocontrast media, immunoglobulins, mannitol
- Distal tubule: NSAIDs (e.g. aspirin, ibuprofen, diclofenac), ACE inhibitors, ciclosporin, lithium salts, cyclophosphamide, amphotericin B
- Tubular obstruction: sulphonamides, methotrexate, aciclovir, diethylene glycol, triamterene.
Acute interstitial nephritis
Main article : Acute interstitial nephritis
- β-lactam antibiotics, vancomycin, rifampicin, sulphonamides, ciprofloxacin, NSAIDs, ranitidine, cimetidine, furosemide, thiazides, phenytoin.
Chronic interstitial nephritis
Acute glomerulonephritis
Drug-induced glomerular disease is not common but there are a few drugs that have been implicated. Glomerular lesions occur primarily through immune-mediated pathways rather than through direct drug toxicity.
Causes of diabetes insipidus
Other nephrotoxins
Diagnosis
Nephrotoxicity is usually monitored through a simple blood test. A decreased creatinine clearance indicates poor kidney function. In interventional radiology, a patient's creatinine clearance levels are all checked prior to a procedure.
Serum creatinine is another measure of kidney function, which may be more useful clinically when dealing with patients with early kidney disease. Normal creatinine level is between 80 - 120 μmol/L.
Etymology
The word nephrotoxicity uses combining forms of nephro- + tox- + -icity, yielding "kidney poisoning".
See also
Further reading
- 10.1038/ncpneph0076 . Drug-associated renal dysfunction and injury . 2006 . Choudhury . Devasmita . Ahmed . Ziauddin . Nature Clinical Practice Nephrology . 2 . 2 . 80–91 . 16932399. 42733127 .
- 15957551 . 2005 . Szeto . CC . Chow . KM . Nephrotoxicity related to new therapeutic compounds . 27 . 3 . 329–33 . Renal Failure . 10.1081/jdi-56595. 6111262 . free .
Notes and References
- Abyar. Selda. Khandar. Ali Akbar. Salehi. Roya. Abolfazl Hosseini-Yazdi. Seyed. Alizadeh. Effat. Mahkam. Mehrdad. Jamalpoor. Amer. White. Jonathan M.. Shojaei. Motahhareh. Aizpurua-Olaizola. O.. Masereeuw. Rosalinde. December 2019. In vitro nephrotoxicity and anticancer potency of newly synthesized cadmium complexes. Scientific Reports. en. 9. 1. 14686. 10.1038/s41598-019-51109-9. 2045-2322. 6789105. 31604983. 2019NatSR...914686A .
- Galley HF . Can acute renal failure be prevented . J R Coll Surg Edinb . 45 . 1 . 44–50 . 2000 . 10815380 . dead . https://web.archive.org/web/20051018104433/http://www.rcsed.ac.uk/journal/vol45_1/4510008.htm . 2005-10-18 .
- Naesens M, Kuypers DR, Sarwal M . Calcineurin inhibitor nephrotoxicity . Clin. J. Am. Soc. Nephrol. . 4 . 2 . 481–509 . 2009 . 19218475 . 10.2215/CJN.04800908. free .
- USMLE WORLD QBanks 2009, Step1, Pharmacology, Q74